Search Results - "Thor Straten, P."

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy by Holmström, M O, Martinenaite, E, Ahmad, S M, Met, Ö, Friese, C, Kjær, L, Riley, C H, thor Straten, P, Svane, I M, Hasselbalch, H C, Andersen, M H

“…The calreticulin ( CALR ) exon 9 mutations are found in ∼30% of patients with essential thrombocythemia and primary myelofibrosis. Recently, we reported…”
Get full text

09.03 Characterization of T cell specificity and exercise-induced dynamics of soluble immunological markers before and after high-intensity aerobic exercise (INHALE) by Leuchte, K, Luu, V, Salo, S, Vinther, A, Thor Straten, P, Olofsson, G

“…BackgroundExercise enhances immune surveillance and prevents the development and recurrence of several cancers. It has been well studied that acute exercise…”
Get full text

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2 by Bjoern, J, Brimnes, M.K, Andersen, M.H, thor Straten, P, Svane, I.M

“…In this study, changes in peripheral blood regulatory T cell (Treg) levels were evaluated in 46 progressive patients with melanoma treated with a dendritic…”
Get full text

The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients by ANDERSEN, M. H, BECKER, J. C, THOR STRATEN, P

Get full text

The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2 neu protein (HER2) as a minor histocompatibility antigen (mHag) by Wenandy, L, Kollgaard, T, Letsch, A, Andersen, R S, Stather, D, Seremet, T, Svane, I M, Vindeløv, L, Andersen, M H, thor Straten, P

Get full text

Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a 'good' mHag? by Kollgaard, T, Hadrup, S Reker, Petersen, S L, Masmas, T N, Andersen, M H, Spierings, E, Vindeløv, L, thor Straten, P

Get full text

Evidence for involvement of clonally expanded CD8 T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation by KOLLGAARD, T, PETERSEN, S. L, HADRUP, S. Reker, MASMAS, T. N, SEREMET, T, ANDERSEN, M. H, MADSEN, H. O, VINDELØV, L, THOR STRATEN, P

“…We have analyzed the clonotype composition of CD8+ T cells following nonmyeloablative (NMA) conditioning and hematopoietic cell transplantation (HCT), of…”
Get full text

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope by Andersen, R S, Wenandy, L, Sørensen, R B, thor Straten, P, Andersen, M H

Get full text

Functional capacity of Mcl-1-specific cytotoxic T-cells by Sørensen, R B, Nielsen, O J, Thor Straten, P, Andersen, M H

Get full text

Identification of an HLA-A1 restricted CTL epitope from Mcl-1 by Andersen, M H, Kvistborg, P, Becker, J C, Thor Straten, P

Get full text

T cell recognition of breast cancer antigens by Ramskov, S., Petersen, N Viborg, Sick Andersen, R., Straten, P Thor, Svane, I-M, Met, Ö, Hadrup, S Reker

Get full text

5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies by Gang, A O, Frøsig, T M, Brimnes, M K, Lyngaa, R, Treppendahl, M B, Grønbæk, K, Dufva, I H, Straten, P thor, Hadrup, S R

“…Treatment with the demethylating agent 5-Azacytidine leads to prolonged survival for patients with myelodysplastic syndrome, and the demethylation induces…”
Get full text

Concurrent disruption of cell cycle associated genes in mantle cell lymphoma : a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb by GRØNBAEK, K, NEDERGAARD, T, ANDERSEN, M. K, THOR STRATEN, P, GULDBERG, P, MØLLER, P, ZEUTHEN, J, EBBE HANSEN, N, HOU-JENSEN, K, RALFKIAER, E

“…Mantle cell lymphomas (MCL) are morphologically and immunophenotypically distinctive lymphoid neoplasms characterised by overexpression of cyclin D1. Recent…”
Get full text

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays by Britten, C. M., Gouttefangeas, C., Welters, M. J. P., Pawelec, G., Koch, S., Ottensmeier, C., Mander, A., Walter, S., Paschen, A., Müller-Berghaus, J., Haas, I., Mackensen, A., Køllgaard, T., thor Straten, P., Schmitt, M., Giannopoulos, K., Maier, R., Veelken, H., Bertinetti, C., Konur, A., Huber, C., Stevanović, S., Wölfel, T., van der Burg, S. H.

“…The interpretation of the results obtained from immunomonitoring of clinical trials is a difficult task due to the variety of methods and protocols available…”
Get full text

A case of lymphoblastoid natural killer (NK)‐cell lymphoma: association with the NK‐cell receptor complex CD94/NKG2 
and TP53 intragenic deletion by Knudsen, H., Grønbæk, K., Thor Straten, P., Gisselø, C., Johansen, P., Timshel, S., Bergmann, O.J., Hansen, N.E., Ralfkiær, E.

“…Summary  The clinical, histological, phenotypic and genotypic features of a lymphoblastoid natural killer (NK)‐cell lymphoma presenting in the skin in a young…”
Get full text

Detection and Characterization of αβ-T-Cell Clonality by Denaturing Gradient Gel Electrophoresis (DGGE) by P. thor Straten, A. Barfoed, T. Seremet, I. Saeterdal, J. Zeuthen, P. Guldberg

“…Accumulation of T cells carrying identical T-cell receptors (TCR) is associated with a number of immunological and nonimmunological diseases. Therefore, it is…”
Get full text

Survivin--a universal tumor antigen by Andersen, M H, thor, Straten P

“…Tumor-associated antigens recognized by cellular effectors of the immune system are potential targets for antigen-specific cancer immunotherapy. These antigens…”
Get full text

P75. Genetic engineering of T cells for increased homing to the tumor site by Idorn, M, Andersen, GH, Larsen, HL, van den Berg, JH, Met, Ö, thor Straten, P

“…Adoptive cell transfer (ACT) using in vitro expanded T cells from biopsy material represents a highly promising treatment of disseminated cancer. ACT in its…”
Get full text

P29. T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from healthy donors by Lyngaa, L, Pedersen, NW, Schrama, D, Thrue, CA, Ibrani, D, Met, O, thor Straten, P, Nghiem, P, Becker, JC, Hadrup, SR

“…PurposeMerkel cell carcinoma (MCC) is a highly aggressive skin cancer with strong evidence for viral carcinogenesis. The association of MCC with the Merkel…”
Get full text

Safety, immunogenicity, and clinical response of a survivin-based peptide vaccine in therapy-resistant advanced cancer: Results from a phase I/II trial by Becker, J. C., Wobser, M., Hofmeister, V., Bauer, B., Broecker, E. B., thor Straten, P., Andersen, M. H.

“…Abstract only…”
Get full text